The Net Clinical Benefit of Rivaroxaban Compared to Low-Molecular-Weight Heparin in the Treatment of Cancer-Associated Thrombosis: Systematic Review and Meta-Analysis

by Mouhand F. H. Mohamed MD, MSc, Mohamad Nabil ElShafei PharmD, Mohamed Badie Ahmed, Lina O. Abdalla MBBS, Israa Ahmed MBBS, Abdel-Naser Elzouki MD, PhD, Mohammed ibn-mas’ud Danjuma MBBS, MSc, PhD
Published 2021-02-01